ramucirumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

General

Pronunciation:
ra-mue-sir-ue-mab


Trade Name(s)

  • Cyramza

Ther. Class.
antineoplastics

Pharm. Class.
vascular endothelial growth factor antagonists

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - ramucirumab ID - 110423 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110423/all/ramucirumab PB - F.A. Davis Company ET - 16 DB - Medicine Central DP - Unbound Medicine ER -